Screener
Zevra Therapeutics, Inc. ZVRA Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Zevra Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Zevra Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001434647-26-000068
FAQ
- What is Zevra Therapeutics, Inc.'s net margin?
- Zevra Therapeutics, Inc. (ZVRA) reported net margin of 42.8% in Q2 2026.
- How has Zevra Therapeutics, Inc.'s net margin changed year-over-year?
- Zevra Therapeutics, Inc.'s net margin increased by 904.4% year-over-year, from 4.3% to 42.8%.
- What is the long-term trend for Zevra Therapeutics, Inc.'s net margin?
- Over 4 years (2020 to 2025), Zevra Therapeutics, Inc.'s net margin has grown at a -5.0% compound annual growth rate (CAGR), from -96% to 78.2%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Zevra Therapeutics, Inc.'s net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude